Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro

Biomaterials

Volumn 28, Issue 25, 2007, Pages 3724-3730

  Jin, Cheng ^a   Bai, Ling ^b   Wu, Hong ^a   Tian, Furong ^a   Guo, Guozhen ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Xi'an Gaoxin Hospital   (China)

Author keywords

Combined radiosensitizers; Etanidazole; Human tumor cells; Hypoxia; Nanoparticle; Paclitaxel

Indexed keywords

CYTOTOXICITY; EMULSIFICATION; EVAPORATION; NANOPARTICLES; ONCOLOGY; SOLVENTS; TUMORS;

COMBINED RADIOSENSITIZERS; DRUG ENCAPSULATION EFFICIENCY (EE); ETANIDAZOLE; HUMAN TUMOR CELLS; HYPOXIA; PACLITAXEL;

DRUG PRODUCTS;

COBALT 60; ETANIDAZOLE; NANOPARTICLE; PACLITAXEL; POLYGLACTIN; RADIOSENSITIZING AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL STRAIN MCF 7; CELL SURVIVAL; CELL VIABILITY; COBALT THERAPY; CONTROLLED STUDY; CYTOTOXICITY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG UPTAKE; ENCAPSULATION; FLUORESCENCE MICROSCOPY; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYPOXIA; PARTICLE SIZE; PRIORITY JOURNAL; RADIOSENSITIZATION; SCANNING ELECTRON MICROSCOPE; SOLID TUMOR; TUMOR CELL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, RADIATION; ETANIDAZOLE; HELA CELLS; HUMANS; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NANOTECHNOLOGY; NEOPLASMS; PACLITAXEL; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS;

EID: 34249823330     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.04.032     Document Type: Article

References (33)

1. Gray L.H., Conger A.D., Ebert M., Hornsey S., and Scott O.C.A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26 (1953) 638-648
2. Bush R.S., Jenkin R.D.T., Allt W.E.C., Beale F.A., Bean H., Dembo A.J., et al. Definitive evidence for hypoxic cells influence in the cure in cancer therapy. Br J Cancer 37 (1978) 302-306
3. Horsman M.R. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumors. Acta Oncol 34 (1995) 571-587
4. Shenoy M.A., and Singh B.B. Chemical radiosensitizers in cancer therapy. Cancer Invest 10 (1992) 533-551
5. Yang R.S., Eckardt J.J., Eilber F.R., Rosen G., Forcher C.A., Dorey F.J., et al. Surgical indications for Ewing's sarcoma of the pelvis. Cancer 76 (1995) 1388-1397
6. Mason K.A., Milas L., and Peters U. Effect of taxol (Paclitaxel) alone and in combination with radiation on the gastrointestinal mucosa. Int J Radiat Oncol Biol Phys 32 (1995) 1381-1389
7. Foa R., Norton L., and Seidman A.D. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity. Int J Clin Lab Res 24 (1994) 6-14
8. Rowinsky E.K., Eisenhower E.A., Chaudry V., Arbuck S.G., and Donehower R.C. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 20 (1993) 1-15
9. Tishler R.B., Schiff P.B., Geard C.R., and Hall E.J. Taxol: a novel radiation sensitizer. Int J Radiat Oncol Biol Phys 22 (1992) 613-617
10. Tishler R.B., Geard C.R., Hall E.J., and Schiff P.B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52 (1992) 3495-3497
11. Terasima R., and Tolrnach L.J. X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells. Science 140 (1963) 490-492
12. Withers H.R., Mason K., Reid B.O., Dubravsky N., Barkely H.T., Brown B.M., et al. Response of mouse intestine to neurons and gamma rays in relation to dose and division cycle. Cancer 34 (1974) 39-47
13. Arbuck S.G. Taxol (paclitaxel): future directions. Ann Oncol 6 (1994) S59-S62
14. Coleman C.N., Wasserman T.H., Urtasun R.C., Halsey J., Hirst V.K., Hancock S., et al. Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule. Int J Radiat Oncol Biol Phys 12 (1986) 1105-1108
15. Lawton C.A., Coleman C.N., Buzydlowski J.W., Forman J.D., Marcial V.A., Delrowe J.D., et al. Results of a Phase II trial of external beam radiation with etanidazole (SR-2508) for the treatment of locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 36 (1996) 673-680
16. Riese N.E., Buswell L., Noll L., Pajak T.F., Stetz J., Lee D.J., et al. Pharacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 Phase III head and neck trial. Int J Radiat Oncol Biol Phys 39 (1997) 855-858
17. O'Dwyer PJ, LaCreta FP. Pharmacology and clinical investigation of SR-2508 (etanidazole). In New drugs, concepts, and results in cancer chemotherapy, 1991. p. 45-63.
18. Brigger I., Dubernet C., and Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliver Rev 54 (2002) 631-651
19. Yuan F., Leuning M., Huang S.K., Berk D.A., Papahadjopoulos D., and Jain R.K. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in human tumor xenograft. Cancer Res 54 (1994) 3352-3356
20. Desai M.P., Labhasetwar V., Walter E., Levy R.J., and Amidon G.L. The mechanism of uptake of biodegradable microparticles in CaCO-2 cells is size dependant. Pharm Res 14 (1997) 1568-1573
21. Feng S.S., Mu L., Win K.Y., and Huang G.F. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem 11 (2004) 413-424
22. ®) loaded poly(lactic-co-glycolicacid) microspheres prepared by spray drying technique with lipid/ cholesterol emulsifiers. J Control Release 76 (2001) 239-254
23. Khin Y.W., and Feng S.S. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(d,l-lactic-co-glycolic acid) nanoparticles for clinical administration of paclitaxel. Biomaterials 27 (2006) 2285-2291
24. Attawia M.A., Borden M.D., Herbert K.M., Katti D.S., Asrari F., Uhrich K.E., et al. Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system. J Control Release 71 (2001) 193-202
25. Negishi T., Koizumi F., Uchino H., Kuroda J., Kawaguchi T., Naito S., et al. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. Br J Cancer 95 (2006) 601-606
26. Wang F.J., and Wang C.H. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents. J Control Release 81 (2002) 263-280
27. Lee T.H., Wang F.J., and Wang C.H. Double-walled microspheres for the sustained release of a highly water soluble drug: characterization and irradiation studies. J Control Release 83 (2002) 437-452
28. Watts M.E., Dennis M.F., and Woodcock M. Uptake and additivity of the radiosensitizing effects of Ro 03-8799 and SR-2508 in mammalian cells in vitro. Br J Radiol 60 (1987) 1233-1235
29. Newman H.F., Ward R., Workman P., and Bleehen N.M. The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole). Int J Radiat Oncol Biol Phys 15 (1988) 1073-1083
30. Jin C, Bai L, Guo GZ. Radiosensitization by the combination of SR-2508 and paclitaxel in hypoxic human tumor cells in vitro. J Radiat Res, 2007, in press, doi:10.1269/jrr.06105.
31. Gupte1 A., and Ciftci K. Formulation and characterization of paclitaxel, 5-FU and paclitaxel+5-FU microspheres. Int J Pharm 276 (2004) 93-106
32. Perez M.H., Siepmann J., Zinutti C., Lamprecht A., Ubrich N., Hoffman M., et al. Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling. J Control Release 88 (2003) 413-428
33. Konan Y.N., Gurney R., and Allemann E. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm 233 (2002) 239-252